Haroche Julien, Amoura Zahir, Wechsler Bertrand, Veyssier-Belot Catherine, Charlotte Frédéric, Piette Jean-Charles
Service de médecine interne, Hôpital Pitié-Salpêtrière, Paris.
Presse Med. 2007 Nov;36(11 Pt 2):1663-8. doi: 10.1016/j.lpm.2007.04.032. Epub 2007 Jul 6.
Erdheim-Chester disease is a non-Langerhans cell histiocytosis, classically thought to be rare, but diagnosed more frequently nowadays (250 published cases). Histiocytes of Erdheim-Chester disease are positive for CD68 but not for CD1a, contrary to Langerhans cell histiocytosis. Two signs highly evocative of this diagnosis are nearly constant tracer uptake by the long bones on (99)Tc bone scintigraphy and a "hairy kidney" appearance on abdominal CT scan. A more "elegant" diagnostic method is ultrasound-guided biopsy of the perirenal infiltration. Cardiovascular involvement, which affects the aorta ("coated aorta") as well as all the cardiac layers, leads to one third of the deaths related to this disease. Central nervous system infiltration (especially cerebellar) is severe and difficult to treat. The prognosis is extremely variable and is often worse when there is a cardiovascular and/or central nervous system involvement. The treatment, decided upon on a case-by-case basis at a specialist center, often begins with interferon alpha.
厄尔德海姆-切斯特病是一种非朗格汉斯细胞组织细胞增多症,传统上认为较为罕见,但如今诊断更为频繁(已发表250例病例)。与朗格汉斯细胞组织细胞增多症相反,厄尔德海姆-切斯特病的组织细胞CD68呈阳性而CD1a呈阴性。该诊断的两个高度提示性征象是,(99)锝骨闪烁显像显示长骨几乎持续摄取示踪剂,以及腹部CT扫描出现“毛肾”表现。一种更“精准”的诊断方法是超声引导下对肾周浸润进行活检。心血管受累,累及主动脉(“包被主动脉”)以及所有心脏层,导致该疾病三分之一的死亡。中枢神经系统浸润(尤其是小脑)严重且难以治疗。预后差异极大,当存在心血管和/或中枢神经系统受累时往往更差。治疗在专科中心根据具体情况决定,通常从干扰素α开始。